MACY MANTOOTH: Open Payments
NPI 1598404055 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 27 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $115 |
| Astellas Pharma US Inc | 4 | $99 |
| ABBVIE INC. | 3 | $64 |
| Dexcom, Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| PFIZER INC. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ABIOMED | 1 | $26 |
| Calliditas Therapeutics US Inc. | 1 | $22 |
| Biogen, Inc. | 1 | $20 |
Products named: Veozah, Ozempic, QULIPTA, Dexcom G6 Transmitter, LEQVIO, SHINGRIX, PREVNAR 20, TARPEYO.
Industry payments across NC — which companies pay providers there.
